Posted by Schess81 on October 19, 2005, at 18:37:28
In reply to Re: Triple reuptake inhibitor trial, posted by CK1 on October 19, 2005, at 17:03:52
You'd think the Triple reuptake inhibitors' clinical effect must be quite simaliar to the MAOIs- although they are slightly different, as MAO is an enzyme that breaks down excess nuerotransmiter in the synapse, and the triple reuptake inhibitors would prevent neurotransmitter reuptake back into the presynaptic neuron. Either way, both are going to increase the amount serotonin, norepiniphrine and dopamine in the synaptic gap. And of course the TRIs wouldnt have the dietary restrictions of the MAOIs.
poster:Schess81
thread:568913
URL: http://www.dr-bob.org/babble/20051017/msgs/568976.html